Heidi Worth
Hematology & Oncology · Birmingham, ALNPI 1417453309
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,435 of the $1,765 with a category attached, or 81.3%. It is spread thinly across 31 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $645 and has fallen 84.5% since, to $100 in 2025. That places this record below the midpoint for hematology & oncology clinicians in AL, where the typical reported total is $7,159.
Across 72 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$172
- Johnson & Johnson$152
- Merck$144
- Pfizer$138
- Bristol Myers Squibb$115
- Amgen$115
- plus $929 from 25 others
What the payments were for
- Food & beverage$1,43581%
- Education$33019%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $172 |
| Johnson & Johnson(2 entities) | 7 | $152 |
| Merck | 6 | $144 |
| Pfizer | 3 | $138 |
| Bristol Myers Squibb | 3 | $115 |
| Amgen | 3 | $115 |
| AstraZeneca(2 entities) | 4 | $103 |
| E.r. Squibb & Sons, L.L.C. | 2 | $101 |
| Sanofi | 4 | $86 |
| Lilly USA, LLC | 4 | $74 |
| Genentech USA, Inc. | 4 | $69 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| AbbVie | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| Novartis | 1 | $29 |
| Sobi, Inc | 1 | $26 |
| EMD Serono, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
| Exelixis Inc. | 1 | $14 |
| Gilead | 1 | $13 |
| Seagen Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
How this compares
$1,765 in reported general payments places this provider in the 25th percentile of 177 hematology & oncology providers in Alabama.
Other hematology & oncology in Birmingham
- Amitkumar MehtaBirmingham$683K
- Pankit VachhaniBirmingham$545K
- Luciano CostaBirmingham$409K
- Khaleel AshrafBirmingham$379K
- Michael BirrerBirmingham$302K
- Rudolph NavariBirmingham$254K
- Mayur NarkhedeBirmingham$193K
- Midhun MallaBirmingham$144K
- Robert ConryBirmingham$143K
- David MooneyBirmingham$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.